Researchers at the University of Illinois have shown for the first time how the activation of a receptor provokes the inflammation and bone degradation of rheumatoid arthritis, and that activation of this one receptor, found on cells in the fluid of arthritic joints, is all that is required.  Their findings point to a new therapeutic target to interrupt the vicious cycle of inflammation and bone erosion … Continue reading Blocking one receptor on cells could halt rheumatoid arthritis.